Target intelligence / Profile preview

Ciprofloxacin

01

Overview

Ciprofloxacin is a **second-generation fluoroquinolone antibiotic** used to treat a wide range of bacterial infections in humans[3][1]. Its chemical name is 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid, with a molecular formula C₁₇H₁₈FN₃O₃ and a molecular weight of about 331.3 g/mol[1][5]. Ciprofloxacin acts by inhibiting bacterial enzymes DNA gyrase (topoisomerase II) and topoisomerase IV, which are essential for bacterial DNA replication, repair, and transcription, leading to bacterial cell death[2][3][4][6][8]. It is active against a variety of Gram-negative and some Gram-positive bacteria, but it is not itself a molecular target[2][4][6]. Safety concerns include the potential for tendon rupture, peripheral neuropathy, central nervous system effects (such as seizures), QT prolongation, and serious hypersensitivity reactions, thus limiting its use to cases without safer or effective alternatives[4][6]. The drug is widely used under multiple brand names and is formulated for oral, intravenous, and topical administration[3][1].\n\nIn summary, "Ciprofloxacin" is a drug, not a biological target such as a receptor, enzyme, or transporter. The true targets of ciprofloxacin are the bacterial enzymes **DNA gyrase (topoisomerase II)** and **topoisomerase IV**. For structured target information, you should query for these enzyme names directly, not the drug itself[2][4].

Other names
CiprofloxacineCiprofloxacinoCiprobayBAY Q 3939CIPROCiproxinCiproCiprofloxacinum
02

Safety considerations

potential for tendon ruptureperipheral neuropathycentral nervous system effects (such as seizures)QT prolongationserious hypersensitivity reactions

Beyond the preview

Go deeper on Ciprofloxacin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ciprofloxacin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call